Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Current Assets (2020 - 2025)

Historic Current Assets for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $325.9 million.

  • Maravai Lifesciences Holdings' Current Assets fell 5201.76% to $325.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $325.9 million, marking a year-over-year decrease of 5201.76%. This contributed to the annual value of $429.1 million for FY2024, which is 3868.57% down from last year.
  • According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' Current Assets is $325.9 million, which was down 5201.76% from $359.8 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Current Assets ranged from a high of $847.9 million in Q4 2022 and a low of $325.9 million during Q3 2025
  • For the 5-year period, Maravai Lifesciences Holdings' Current Assets averaged around $628.7 million, with its median value being $681.5 million (2024).
  • In the last 5 years, Maravai Lifesciences Holdings' Current Assets soared by 12317.35% in 2021 and then crashed by 5201.76% in 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Current Assets (Quarter) stood at $740.0 million in 2021, then rose by 14.58% to $847.9 million in 2022, then fell by 17.45% to $699.9 million in 2023, then tumbled by 38.69% to $429.1 million in 2024, then decreased by 24.07% to $325.9 million in 2025.
  • Its last three reported values are $325.9 million in Q3 2025, $359.8 million for Q2 2025, and $376.3 million during Q1 2025.